| RS2526329989 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2526330524 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS2526332292 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS2526337540 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2526339061 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2526340934 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS2526341517 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS2526341854 |
FMO3
|
Health Risk |
Likely pathogenic |
— |
| RS2526345528 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526345779 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526347472 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2526352822 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS2526354513 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526358716 |
F5
|
Health Risk |
Likely pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526362315 |
FMO3
|
Health Risk |
Likely pathogenic |
— |
| RS2526362421 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS2526364101 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 3 |
| RS2526364384 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Pheochromocytoma/paraganglioma syndrome 3 |
| RS2526364668 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Pheochromocytoma/paraganglioma syndrome 3 |
| RS2526364684 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 3 |
| RS2526364876 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS2526365022 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS2526365241 |
CHRNB2
|
Health Risk |
Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 3, Autosomal dominant nocturnal frontal lobe epilepsy 3 |
| RS2526365751 |
SDHC
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS2526370283 |
DHX9
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS2526373039 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526373514 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526376369 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526376498 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526376882 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526377834 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526377906 |
DHX9
|
Health Risk |
Pathogenic/Likely pathogenic |
DHX9-related disorder, Intellectual developmental disorder |
| RS2526378323 |
NPHS2
|
Health Risk |
Pathogenic |
— |
| RS2526378544 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2526378629 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS2526378772 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526378815 |
F5
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526379067 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS2526379548 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS2526380091 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526380104 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526380257 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526380602 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS2526381814 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526382945 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526383039 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526383275 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2526387037 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526387234 |
F5
|
Health Risk |
Pathogenic |
— |
| RS2526387778 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526389374 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526391147 |
HSD3B2
|
Health Risk |
Likely pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, HSD3B2-related disorder |
| RS2526391252 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526391280 |
HSD3B2
|
Health Risk |
Likely pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS2526391378 |
HSD3B2
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia, Congenital adrenal hyperplasia |
| RS2526391548 |
CNTN2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526391994 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526392181 |
CNTN2
|
Health Risk |
Pathogenic |
— |
| RS2526392189 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526392374 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526392619 |
HSD3B2
|
Health Risk |
Pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS2526392825 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526392908 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2526393548 |
HSD3B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital adrenal hyperplasia, Congenital adrenal hyperplasia |
| RS2526394168 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2526394415 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526394528 |
HSD3B2
|
Health Risk |
Likely pathogenic |
— |
| RS2526394921 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526395115 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526395906 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2526399084 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly |
| RS2526400673 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526400748 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526402037 |
DHX9
|
Health Risk |
Pathogenic |
— |
| RS2526402294 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2526402741 |
CD46
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2526403709 |
ECM1
|
Health Risk |
Likely pathogenic |
ECM1-related disorder, ECM1-related disorder |
| RS2526412851 |
ECM1
|
Health Risk |
Likely pathogenic |
Lipid proteinosis, Lipid proteinosis |
| RS2526413187 |
CNTN2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526418181 |
CNTN2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526418803 |
F5
|
Health Risk |
Likely pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526419037 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2526429943 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS2526430459 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526430620 |
F5
|
Health Risk |
Likely pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526433101 |
PRG4
|
Health Risk |
Pathogenic |
— |
| RS2526436644 |
CD46
|
Health Risk |
Pathogenic |
— |
| RS2526436760 |
LEPR
|
Health Risk |
Pathogenic |
— |
| RS2526439935 |
DHX9
|
Health Risk |
Likely pathogenic |
— |
| RS2526439955 |
DHX9
|
Health Risk |
Likely pathogenic |
DHX9-related neurodevelopmental disorder, DHX9-related neurodevelopmental disorder |
| RS2526444928 |
PRG4
|
Health Risk |
Pathogenic |
— |
| RS2526445197 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS2526445474 |
F5
|
Health Risk |
Likely pathogenic |
Thrombophilia due to activated protein C resistance, Thrombophilia due to activated protein C resistance |
| RS2526445575 |
F5
|
Health Risk |
Likely pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS2526449355 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Symmetrical dyschromatosis of extremities |
| RS2526449847 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS2526450124 |
ADAR
|
Health Risk |
Pathogenic |
— |
| RS2526450332 |
PRG4
|
Health Risk |
Likely pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2526451293 |
NRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2526451323 |
NRAS
|
Health Risk |
Likely pathogenic |
Pyogenic granuloma, Pyogenic granuloma |